Organization
Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany
5 abstracts
Abstract
ADHERENCE TO PUBLISHED GUIDELINES ON TB SCREENING BEFORE THE START OF TREATMENT WITH BIOLOGICS IN GERMANYOrg: Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany,
Abstract
ANTI-SACHCCAROMYCES CEREVISIAE ANTIBODIES AND DISEASE ACTIVITY IN ANKYLOSING SPONDYLITIS: CLINICAL CORRELATIONSOrg: Rheumatology Division, Laboratory unit, Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany, Hospital Universitario Juan Canalejo, La Coruña, Spain,
Abstract
ARE WE ASKING THE RIGHT QUESTIONS IN TRANSITION RESEARCH? Org: Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany, Charite Universitätsmedizin, Berlin, Germany,
Abstract
ANTICARDIOLIPIN ANTIBODIES AS A RISK FACTOR FOR RENAL RELAPSE IN PATIENTS WITH SYSTEMIC LUPUS ERITHEMATOSUSOrg: Rheumatology unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden, Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany, Investigation Unit, UMAE CMNR HE Dr. Antonio Fraga Mouret IMSS, Mexico City, Mexico,
Abstract
BIOLOGIC TREATMENT IN ELDERLY PATIENTS: SPECIFIC SAFETY CONCERNS Org: Epidemiology Unit, German Rheumatism Research Centre, Berlin, Germany,